Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Disease area: Airway diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mohamed, K. Shibuya, I. Yoshino, Y. Nakatani (Assuit, Egypt; Chiba, Japan). Inducible nitric oxide synthase as a predictor for progression to lung cancer in patients with bronchial squamous dysplasia, a per patient analysis. Eur Respir J 2012; 40: Suppl. 56, 763

Member's Comments

No comment yet.

Related content which might interest you: Measurement of alveolar nitric oxide in patients with lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Acinar and bronchial nitric oxide levels in stable and exacerbated COPD. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Expression of inducible nitiric oxide synthase (iNOS) in airway epithelial cells is reduced in young children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients? Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Nitric oxide synthase gene expression and its relation with the lung vascular injury in pneumonia of immunosupressed rats Source: Eur Respir J 2005; 26: Suppl. 49, 731s Year: 2005 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Gene polymorphisms of endothelial nitric oxide synthase in patients with mild and moderate bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 524s Year: 2006 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019 The impact of lung cancer subtypes, smoking status and corticosteroid treatment on exhaled nitric oxide levels in patients with lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 Specific localisation of nitric oxide synthase in human nasal mucosa Source: Eur Respir J 2004; 24: Suppl. 48, 585s Year: 2004 Upregulation of the inducible form of the nitric oxide synthase and nitrotyrosine formation in skeletal muscle of COPD patients with cachexia Source: Eur Respir J 2002; 20: Suppl. 38, 211s Year: 2002 Increased levels of fractional exhaled nitric oxide after chemotherapy for lung cancer. Ongoing study Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001 Exhaled nitric oxide levels and severity of bronchopulmonary dysplasia (BPD) development Source: Eur Respir J 2007; 30: Suppl. 51, 745s Year: 2007